Can multivitamins slow biological aging?
Small pills, measurable signals
A controlled study has found that daily multivitamin supplementation produced modest but detectable slowing of some biomarkers associated with biological ageing over the trial period. Participants who took a multivitamin every day for the study duration showed improvements on selected molecular and physiological markers used by researchers to estimate ‘‘biological age’’ — a metric intended to capture functional rather than chronological wear and tear.
Who benefited most and what it means
The observed anti‑ageing effect was not uniform. People whose biomarkers already indicated older biological ages experienced a larger benefit from supplementation than those who were biologically younger at baseline. This pattern suggests multivitamins may help correct micronutrient insufficiencies or metabolic imbalances that contribute to accelerated ageing in some individuals, rather than acting as a universal rejuvenator.
Practical takeaways
- Supplements are not a panacea: Effects were modest and limited to certain biomarkers, not sweeping improvements in clinical health outcomes.
- Targeted value: Individuals with poorer baseline nutritional status or older biological markers appeared to gain more measurable benefit.
- Need for longer follow-up: The trial length captured short‑to‑medium term biomarker changes; whether these translate into reduced disease, frailty, or mortality over years remains unproven.
Caveats and next steps
Researchers urge caution in interpreting the results. Biomarkers are useful proxies but do not equal hard clinical endpoints. The study helps justify larger and longer trials that track disease incidence and functional health. Meanwhile, it reinforces the public‑health message that meeting nutritional needs matters for healthy ageing, and that routine supplementation might be most valuable for those with poor dietary intake or demonstrable deficiencies.